Further assessment found indications of a similar elevation pattern of other glycolytic markers in AD, such as triosephosphate isomerase (TPI1), alpha and gamma enolase (ENO1; ENO2) in both CSF and publicly available tissue data. This evidence concerns the gene TPI1 and Alzheimer disease.